143 related articles for article (PubMed ID: 26706501)
21. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
Sousa A; Souza KC; Sousa EM
Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431
[TBL] [Abstract][Full Text] [Related]
22. Synthesis Mechanism and Thermal Optimization of an Economical Mesoporous Material Using Silica: Implications for the Effective Removal or Delivery of Ibuprofen.
Kittappa S; Cui M; Ramalingam M; Ibrahim S; Khim J; Yoon Y; Snyder SA; Jang M
PLoS One; 2015; 10(7):e0130253. PubMed ID: 26161510
[TBL] [Abstract][Full Text] [Related]
23. Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.
Kwon S; Singh RK; Kim TH; Patel KD; Kim JJ; Chrzanowski W; Kim HW
Acta Biomater; 2014 Mar; 10(3):1431-42. PubMed ID: 24239681
[TBL] [Abstract][Full Text] [Related]
24. Effective controlled release of captopril by silylation of mesoporous MCM-41.
Qu F; Zhu G; Huang S; Li S; Qiu S
Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
[TBL] [Abstract][Full Text] [Related]
25. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
Yang P; Quan Z; Li C; Kang X; Lian H; Lin J
Biomaterials; 2008 Nov; 29(32):4341-7. PubMed ID: 18715638
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of MCM-48/hydroxyapatite composites for drug delivery: Ibuprofen incorporation, location and release studies.
Pajchel L; Kolodziejski W
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():734-742. PubMed ID: 30033308
[TBL] [Abstract][Full Text] [Related]
27. A Biodegradation Study of SBA-15 Microparticles in Simulated Body Fluid and in Vivo.
Choi Y; Lee JE; Lee JH; Jeong JH; Kim J
Langmuir; 2015 Jun; 31(23):6457-62. PubMed ID: 26013363
[TBL] [Abstract][Full Text] [Related]
28. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
[TBL] [Abstract][Full Text] [Related]
29. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
[TBL] [Abstract][Full Text] [Related]
30. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
31. Examining Insulin Adsorption onto Mesoporous Silica Microparticles for Oral Delivery.
Eilleia SY; Soliman ME; Niedermayer S; Schmidt A; Mansour S; Geneidi AS
Curr Drug Deliv; 2018; 15(4):541-553. PubMed ID: 28969564
[TBL] [Abstract][Full Text] [Related]
32. Development of novel delivery system for warfarin based on mesoporous silica: adsorption characteristics of silica materials for the anticoagulant.
Dolinina ES; Vorobyeva EV; Parfenyuk EV
Pharm Dev Technol; 2016 Aug; 21(5):546-53. PubMed ID: 26465269
[TBL] [Abstract][Full Text] [Related]
33. Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.
Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
Eur J Pharm Sci; 2016 Aug; 91():225-35. PubMed ID: 27189528
[TBL] [Abstract][Full Text] [Related]
34. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
35. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
[TBL] [Abstract][Full Text] [Related]
36. [Mesoporous nano-bioactive glass microspheres as a drug delivery system of minocycline].
Zhu L; Wang YD; Dong YM; Chen XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):249-253. PubMed ID: 29643523
[TBL] [Abstract][Full Text] [Related]
37. A luminescent and mesoporous core-shell structured Gd2O3 : Eu(3+)@nSiO2@mSiO2 nanocomposite as a drug carrier.
Xu Z; Gao Y; Huang S; Ma Pa; Lin J; Fang J
Dalton Trans; 2011 May; 40(18):4846-54. PubMed ID: 21431226
[TBL] [Abstract][Full Text] [Related]
38. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
[TBL] [Abstract][Full Text] [Related]
39. Growth of hydroxyapatite in a biocompatible mesoporous ordered silica.
Díaz A; López T; Manjarrez J; Basaldella E; Martínez-Blanes JM; Odriozola JA
Acta Biomater; 2006 Mar; 2(2):173-9. PubMed ID: 16701875
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of hierarchical porous bioactive glasses for bone tissue regeneration.
Ma J; Lin H; Li X; Bian C; Xiang D; Qu F
IET Nanobiotechnol; 2014 Dec; 8(4):216-21. PubMed ID: 25429500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
